Company Filing History:
Years Active: 2013-2019
Title: **Sunita Borsadia: Innovator in Protein Formulations**
Introduction
Sunita Borsadia, an accomplished inventor based in Plainsboro, NJ, has made significant strides in the field of biopharmaceuticals. With a total of three patents to her name, her contributions have the potential to impact the treatment of immune system diseases profoundly.
Latest Patents
Among her notable patents is the innovative work on "Stable subcutaneous protein formulations and uses thereof." This invention pertains to stable formulations comprising CTLA4Ig molecules, including both lyophilized and liquid forms, designed for administration through various routes, such as intravenous (IV) and subcutaneous (SC). These formulations aim to treat immune system diseases and promote tolerance induction, showcasing her commitment to advancing medical technology.
Career Highlights
Sunita works at Bristol-Myers Squibb Company, a leading global biopharmaceutical company. Her role at this esteemed organization allows her to leverage her expertise in developing products that address critical health challenges.
Collaborations
Throughout her career, Sunita has collaborated with esteemed colleagues, including Charles E. Dahlheim and Vijay H. Naringrekar. These partnerships highlight the importance of teamwork in driving innovation and finding effective solutions in the pharmaceutical industry.
Conclusion
Sunita Borsadia exemplifies the spirit of innovation in the field of biopharmaceuticals through her groundbreaking inventions. Her work not only contributes to the advancement of science but also offers hope for many individuals affected by immune system diseases.